IDiyas

For the Inventor, By the Inventor

Fremont, CA, United States of America

Rama Jain

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 11.6

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Danville, CA (US) (2023)
  • Fremont, CA (US) (2009 - 2024)
  • Emeryville, CA (US) (2023 - 2024)

Company Filing History:

goldMedal11 out of 3,923 
 
Novartis Ag
 patents
silverMedal3 out of 245 
 
Novartis Vaccines & Diagnostics, Gmbh
 patents

Years Active: 2009-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):
1. 12252482 - Pyrazolopyridine derivatives and uses thereof (2025-03-18),
2. 12172984 - Pyrazolopyridine derivatives and uses thereof (2024-12-24),
3. 12071441 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza (2024-08-27),
4. 11912715 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections (2024-02-27),
5. 11787785 - Pyrazolopyridine derivatives and uses thereof (2023-10-17),
6. 11629149 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza (2023-04-18),
7. 11453677 - Tricyclic compounds useful to treat orthomyxovirus infections (2022-09-27),
8. 11098051 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections (2021-08-24),
9. 10858366 - Tricyclic compounds useful to treat orthomyxovirus infections (2020-12-08),
10. 10160764 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections (2018-12-25),
11. 8735599 - Substituted imidazole derivates (2014-05-27),
12. 8318791 - Substituted imidazole derivatives (2012-11-27),
13. 7932262 - Quinazolines for PDK1 inhibition (2011-04-26),
14. 7576221 - Substituted imidazole derivatives (2009-08-18),

Title: Rama Jain: Pioneering Innovation in the Technological Landscape

Introduction:

Rama Jain, a visionary inventor based in Fremont, CA (US), is a prominent figure whose passion for innovation and relentless pursuit of excellence continue to inspire the next generation of inventors. With 11 patented inventions under her name, Rama Jain is making significant contributions to the ever-evolving landscape of technology.

Latest Patents:

Rama Jain's latest patents showcase her ingenuity and dedication to advancing the field of medicine and healthcare. One of her recent inventions includes fused tricyclic pyridazinone compounds that are useful in treating orthomyxovirus infections, particularly influenza. Another groundbreaking patent involves pyrazolopyridine derivatives, which are utilized in reducing Widely Interspaced Zinc Finger Motifs (WIZ) expression levels and treating inherited blood disorders such as sickle cell disease and beta-thalassemia.

Career Highlights:

Throughout her illustrious career, Rama Jain has been associated with prominent companies like Novartis AG and Novartis Vaccines & Diagnostics GmbH (Novartis). Her tenure at these organizations has allowed her to delve into cutting-edge research and development, leading to the creation of innovative solutions that have the potential to transform healthcare practices globally.

Collaborations:

Rama Jain's collaborative spirit is evident in her work alongside accomplished individuals in the field. Noteworthy colleagues include James R Manning and Dennis Christofer Koester, with whom she has collaborated on projects that push the boundaries of scientific discovery and technological innovation.

Conclusion:

In conclusion, Rama Jain stands as a beacon of innovation, driving positive change in the technological sphere through her groundbreaking inventions and unwavering commitment to excellence. Her legacy serves as a testament to the transformative power of innovation, inspiring inventors and researchers to push boundaries and redefine what is possible in the world of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…